News

PulmoHeal® has been proven by third-party organizations to be effective and safe in treating pulmonary fibrosis

PulmoHeal® has been validated by a third-party organization as an effective and safe treatment for pulmonary fibrosis, and the results of preclinical trials are positive.
The results of the third-party study showed that PulmoHeal® was effective in treating BLM-induced pulmonary fibrosis in both mice and rats, and that after treatment with PulmoHeal®, the BLM-induced lung structure was restored to the normal group with no significant toxicological effects, demonstrating the safety of PulmoHeal®.